Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT03807037

Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation

Safety of Tocotrienols in Atrial Fibrillation After Coronary Artery Bypass Grafting Surgery: A Randomized Controlled Exploratory Trial

Sponsor: Institut Jantung Negara

Conditions Atrial Fibrillation

Interventions Placebo oral capsule Tocotrienols

Updated 9 times since 2019 Last updated: Aug 23, 2022 Started: Dec 17, 2018 Primary completion: Dec 30, 2021 Completion: Dec 30, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Atrial Fibrillation, this trial is completed. The trial is conducted by Institut Jantung Negara and has accumulated 9 data snapshots since 2018. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Sep 2022 — Jul 2024 [monthly]

Completed PHASE2_PHASE3

Status: Recruiting → Completed
Mar 2021 — Sep 2022 [monthly]

Recruiting PHASE2_PHASE3
Jan 2021 — Mar 2021 [monthly]

Recruiting PHASE2_PHASE3

▶ Show 4 earlier versions

Jun 2020 — Jan 2021 [monthly]

Recruiting PHASE2_PHASE3
May 2020 — Jun 2020 [monthly]

Recruiting PHASE2_PHASE3
Apr 2019 — May 2020 [monthly]

Recruiting PHASE2_PHASE3
Feb 2019 — Apr 2019 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Dec 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Institut Jantung Negara
Monash University Malaysia

Data source: Monash University Malaysia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kuala Lumpur, Malaysia